Low-dose steroids associated with milder histological changes after pediatric liver transplantation

Liver Transplantation

Volumn 19, Issue 2, 2013, Pages 145-154

  Kosola, Silja ^a   Lampela, Hanna ^a   Jalanko, Hannu ^a   Mäkisalo, Heikki ^a   Lohi, Jouko ^b   Arola, Johanna ^b   Pakarinen, Mikko P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BILIRUBIN GLUCURONIDE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREALBUMIN; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BODY MASS; CHILD; CHOLESTASIS; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATTY LIVER; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER HEMATOMA; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PEDIATRIC SURGERY; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEROID THERAPY; SURVIVOR; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY LIVER; FEMALE; FINLAND; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PREDICTIVE VALUE OF TESTS; STEROIDS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873621278     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23565     Document Type: Article

References (36)

1. Berenguer M, Rayõn JM, Prieto M, Aguilera V, Nicolás D, Ortiz V, et al. Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 2001; 7: 790-796. (Pubitemid 32851300)
2. Sebagh M, Rifai K, Féray C, Yilmaz F, Falissard B, Roche B, et al. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 2003; 37: 1293-1301. (Pubitemid 36667308)
3. Mells G, Neuberger J,. Protocol liver allograft biopsies. Transplantation 2008; 85: 1686-1692.
4. Hübscher S,. What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 2009; 15 (suppl 2): S19-S24.
5. Evans HM, Kelly DA, McKiernan PJ, Hübscher S,. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117. (Pubitemid 43724635)
6. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM,. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587.
7. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS,. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880-886.
8. Aguilera I, Sousa JM, Gavilan F, Gomez L, Alvarez-Márquez A, Núñez-Roldán A,. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl 2011; 17: 779-788.
9. Bateman AC, Hübscher SG,. Cytokeratin expression as an aid to diagnosis in medical liver biopsies. Histopathology 2010; 56: 415-425.
10. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 89-96. (Pubitemid 26249418)
11. Berenguer M, Prieto M, San Juan F, Rayõn JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202-210. (Pubitemid 34700779)
12. Martin SR, Atkison P, Anand R, Lindblad AS,; for SPLIT Research Group. Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004; 8: 273-283. (Pubitemid 38788556)
13. Sieders E, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Zwaveling JH, et al. Graft loss after pediatric liver transplantation. Ann Surg 2002; 235: 125-132. (Pubitemid 34062408)
14. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005; 11: 152-160. (Pubitemid 40268212)
15. Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L,. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med 2011; 43: 235-248.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
17. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z,. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17: 15-22.
18. Banff Working Group, Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501. (Pubitemid 44214890)
19. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20 (pt 1): 15-20.
20. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344: 495-500. (Pubitemid 32164902)
21. Bell LE, Bartosh SM, Davis CL, Dobbels F, Al-Uzri A, Lotstein D, et al. Adolescent transition to adult care in solid organ transplantation: a consensus conference report. Am J Transplant 2008; 8: 2230-2242.
22. McDiarmid SV,. 21 years old-who cares? Am J Transplant 2012; 12: 1367-1369.
23. Al-Sinani S, Dhawan A,. Corticosteroids usage in pediatric liver transplantation: to be or not to be! Pediatr Transplant 2009; 13: 160-170.
24. Guthery SL, Pohl JF, Bucuvalas JC, Alonso MH, Ryckman FC, Balistreri WF, Heubi JE,. Bone mineral density in long-term survivors following pediatric liver transplantation. Liver Transpl 2003; 9: 365-370. (Pubitemid 36443048)
25. Hübscher SG,. What is the long-term outcome of the liver allograft? J Hepatol 2011; 55: 702-717.
26. Shaikh OS, Demetris AJ,. Idiopathic posttransplantation hepatitis? Liver Transpl 2007; 13: 943-946. (Pubitemid 47163182)
27. Peeters PM, Sieders E, vd Heuvel M, Bijleveld CM, de Jong KP, TenVergert EM, et al. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation 2000; 70: 1581-1587. (Pubitemid 32037970)
28. Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F,. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl 2008; 14: 946-955. (Pubitemid 352003893)
29. Desmet VJ,. Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered. Virchows Arch 2011; 458: 251-259.
30. Desmet VJ,. Ductal plates in hepatic ductular reactions. Hypothesis and implications. II. Ontogenic liver growth in childhood. Virchows Arch 2011; 458: 261-270.
31. Hoare M, Das T, Alexander G,. Ageing, telomeres, senescence, and liver injury. J Hepatol 2010; 53: 950-961.
32. Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ,. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl 2009; 15: 1662-1670.
33. Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol 2010; 105: 613-620.
34. Boström P, Rutberg M, Ericsson J, Holmdahl P, Andersson L, Frohman MA, et al. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler Thromb Vasc Biol 2005; 25: 1945-1951. (Pubitemid 41243467)
35. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al.; for Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321. (Pubitemid 40770284)
36. Kosola S, Lampela H, Gylling H, Jalanko H, Nissinen MJ, Lauronen J, et al. Cholesterol metabolism altered and FGF21 levels high after pediatric liver transplantation despite normal serum lipids. Am J Transplant 2012; 12: 2815-2824.